Operating income · 2019–2025

Universe Pharmaceuticals operating income

−$2.9B+$5.1B · FY2025

Universe Pharmaceuticals (UPC) reported −$2.9B in operating income for fiscal 2025, +$5.1B from the year before.

$9.8M2019$10.3M2020$13.6M2021−$7.0M2022−$4.0B2023−$8.0B2024−$2.9B2025
Universe Pharmaceuticals — Operating income, 2019–2025
Fiscal yearOperating incomeChangeFiling
FY20252025-09-30−$2.9B+$5.1BOpen →
FY20242024-09-30−$8.0B−$4.1BOpen →
FY20232023-09-30−$4.0B−$4.0BOpen →
FY20222022-09-30−$7.0M−$20.6MOpen →
FY20212021-09-30$13.6M+32.6%Open →
FY20202020-09-30$10.3M+5.1%Open →
FY20192019-09-30$9.8M—Open →

Operating income — Operating income is profit from the core business before interest and tax. It strips out financing decisions, so it compares operations rather than balance sheets.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Operating income at companies of similar size

Full ranking by operating income →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Universe Pharmaceuticals operating income |url=https://companiesranked.com/en/company/universe-pharmaceuticals/operating-income |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Universe Pharmaceuticals operating income. CompaniesRanked. https://companiesranked.com/en/company/universe-pharmaceuticals/operating-income

BibTeX

@misc{companiesranked-en-company-universe-pharmaceuticals-operating-income-2026,
  author       = {{CompaniesRanked}},
  title        = {{Universe Pharmaceuticals operating income}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/universe-pharmaceuticals/operating-income}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001213900-26-009000 · January 29, 2026

{{cite web |title=Universe Pharmaceuticals operating income — 20-F (0001213900-26-009000) |url=https://www.sec.gov/Archives/edgar/data/1809616/000121390026009000/ea0273969-20f_universe.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-01-29}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Universe Pharmaceuticals overview